Protocols

The clinical literature on shilajit dosing protocols is extremely limited. Based on available evidence from completed clinical trials, typical administration approaches include:

General Dosing Patterns:

Most clinical studies appear to use shilajit as part of combination formulations rather than as a standalone supplement
Trials have investigated shilajit in combination with other compounds such as chromium, Phyllanthus emblica, and various plant extracts
One completed trial (NCT02026414) specifically examined "PrimaVie" (a standardized shilajit extract) in combination with exercise training

Formulation Considerations:

Clinical investigations have used standardized extracts rather than raw shilajit
Studies have incorporated shilajit into multi-ingredient dietary supplements
Research has focused on specific applications including glucose control, cardiovascular health, and exercise performance

Duration and Administration:

Specific dosing amounts, frequencies, and treatment durations are not clearly reported in the available evidence
Most trials appear to be relatively short-term interventions

Critical Evidence Limitations:
The current evidence base provides insufficient detail regarding optimal dosing protocols for shilajit. The available clinical trial registry information lacks specific dosing parameters, and the research literature focuses primarily on compositional analysis and preclinical studies rather than clinical dosing guidelines.

Important Disclaimer:
This information is not personalized medical advice. Dosing protocols should be determined in consultation with a qualified healthcare provider who can assess individual health status, potential drug interactions, and appropriate therapeutic goals. The safety and efficacy of shilajit supplementation may vary significantly between individuals and product formulations.

Shilajit

Member access required